Non-Hodgkin Lymphoma | Tumor

A Song for Cancer Survivors

May 27th 2018, 12:23am

This is what surviving cancer sounds like.

Navigating the Waves of Cancer Treatment

May 17th 2018, 4:53pm

In this week’s episode of CURE Talks Cancer, we spoke with Matt Lashey, creator and CEO of the chemoWave app, which is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being to understand how their experiences may be related to feeling better or worse during treatment.

Genomic Analysis Points to More Effective Treatment Options in Lymphoma Subtype

May 15th 2018, 5:18pm

Thanks to genomic analysis by scientists at the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard, diffuse large B cell lymphoma (DLBCL) is now a little easier to understand – and possibly easier to treat.

Long, Long Ago, on an Island Far, Far Away

May 9th 2018, 5:42pm

chemoWave Propels Patients to Take Back Control in Cancer Treatment

May 8th 2018, 12:46am

The chemoWave app, launched in July 2017, is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being.

Study Demonstrates Potential for New CLL Combination

March 9th 2017, 2:00am

A recent phase 3 study showed that Imbruvica plus ublituximab may be a promising option for some patients with CLL.

The Potential of Gazyva in Advanced Indolent Non-Hodgkin Lymphoma

June 29th 2015, 8:00pm

CURE spoke with Bruce D. Cheson to gain a deeper understanding of adding the targeted therapy Gazyva to the chemotherapy Treanda for patients with Rituxan-refractory indolent non-Hodgkin lymphoma.

A Focus on a Cure for Non-Hodgkin Lymphoma

November 22nd 2014, 7:40am

Most non-Hodgkin lymphomas can be cured, but new drugs are needed.

Pipeline

September 25th 2014, 9:01pm

The latest in cancer prevention, diagnosis and treatment.